RxDoctor Payments Data

Armani Orihuela, MD

Family Medicine · Sarasota, FLNPI 1013443506

Payments from drug & device makers

$10,297in general payments, 2019–2025

Across 599 payments — averaging $17.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$1K
  • AbbVie$1K
  • Pfizer$1K
  • Bayer$792
  • GSK$737
  • Sumitomo Pharma America, Inc.$627
  • plus $5K from 43 others

What the payments were for

  • Food & beverage$10,297100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$10,297 in reported general payments places this provider in the 90th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$353,361
Medicare patients
1,014
Services billed
4,006

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban169$202,167
MounjaroTirzepatide153$171,466
JardianceEmpagliflozin74$108,392
OzempicSemaglutide65$82,163
XareltoRivaroxaban48$59,713
TrulicityDulaglutide43$56,711
Trelegy ElliptaFluticasone/Umeclidin/Vilanter70$49,227
JanuviaSitagliptin Phosphate37$41,652
EntrestoSacubitril/Valsartan36$40,723
FarxigaDapagliflozin Propanediol30$35,855
GemtesaVibegron21$17,564
MyrbetriqMirabegron17$15,458
LinzessLinaclotide14$11,212
Atorvastatin Calcium749$6,653
Breo ElliptaFluticasone/Vilanterol13$5,205

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$1,168$228,177196 claims
PfizerEliquis$1,018$202,167169 claims
Boehringer IngelheimJardiance$331$108,39274 claims
Novo NordiskOzempic$559$82,16365 claims
Johnson & JohnsonXarelto$43$59,71348 claims
GSKTrelegy Ellipta, Breo Ellipta$737$54,43183 claims
MerckJanuvia$548$41,65237 claims
NovartisEntresto$198$40,72336 claims
AstraZenecaFarxiga$450$35,85530 claims
Sumitomo Pharma America, Inc.Gemtesa$627$17,56421 claims
Astellas Pharma US IncMyrbetriq$12$15,45817 claims
AbbVieLinzess, Synthroid$1,141$14,25345 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Sarasota

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →